뉴잉글랜드바이오랩스(NEB)는 지난 50여 년간 과학의 발전을 최우선 가치로 삼아왔습니다. 우리는 연구자 여러분과 NEB의 자체 연구를 함께 발전시킬 수 있도록, 고품질의 혁신적인 제품 개발에 전념하고 있습니다. 과학이 인류 건강 증진과 세상에 대한 이해에 기여한다는 사실을 깊이 인식하며, 여러분의 소중한 연구를 지원하게 되어 영광입니다. NEB는 앞으로도 여러분과 함께 내일의 과학을 만들어 나가고자 합니다.
Highest capacity RNA cleanup of up to 3 mg per column using silica spin columns. Optimized for IVT RNA, modified nucleotides, and fast benchtop workflows.
High‑fidelity (~280× Taq) polymerase enables fast amplification of diverse targets up to 20 kb, with a hot-start setup, short extension times, and a 62°C universal annealing protocol.
This article traces molecular cloning’s history and progress, highlighting how improved enzymes, assembly methods, and DNA design tools have advanced cloning efficiency, precision and applications.
The NEBaseChanger® Primer Design Tool Tutorial video will explain how to design primers for site-directed and multi-site mutagenesis using NEBaseChanger. This tool is ideal for NEB Q5® and NEBuilder® HiFi DNA Assembly applications.
Read about how RNase 4 enables targeted isolation and LC-MS analysis of mRNA 5' cap structures, supporting accurate assessment of capping efficiency and mRNA critical quality attributes (CQAs).
The latest version of NEBaseChanger® is available to help design site-directed mutagenesis primers. Compatible with ambiguous bases, substitute based on amino acid position, batch upload for multiple primer sets and add mutations to primer tails.
Explore NEB Expressions, featuring a precision medicine case study from discovery to targeted therapy, cell-free dbDNA synthesis, enzymatic solutions for circular RNA enrichment, conservation efforts in Costa Rica, RNA workflow products and the 2026 Passion in Science Awards.
Accelerating RNA & DNA Therapeutics with Cell-free DNA Synthesis
Featured Webinar
Accelerating RNA & DNA Therapeutics with Cell-free DNA Synthesis
Learn about cell-free DNA synthesis for RNA and DNA therapeutics with a focus on closed-ended DNA inputs and an overview of the recent launch of our new EnClose™ Cell-free dbDNA Synthesis Kit.
Highly Efficient Peptide Binder Discovery Using mRNA Display
Posted on Monday, August 24, 2026
By
Nicole Kelesoglu
& Illustration by Tasha Jose
In this interview, PeptiFinder Biotech scientists share why mRNA Display is such a powerful platform for peptide therapeutics discovery, where they see this field going, and how enzyme engineering and workflow optimization could further expand the chemical space accessible to mRNA display.
RNase III Protocol Modification Can Enable Safe dsRNA Removal from IVT Samples
Posted on Monday, July 20, 2026
By
Iris Martinez, Illustrations by Tasha José
High-quality and pure RNA is a requirement for RNA therapeutics to avoid unwanted immune responses, not just a “nice to have.” In vitro transcription can be optimized, but additional cleanup may be needed. Enzymatic removal of dsRNA using RNase III preserves ssRNA integrity when refined using a protocol developed by NEB scientists.
Cell-free Protein Synthesis Enables Rapid Single-chain Fragment Production and Analysis
Posted on Thursday, July 9, 2026
By
Iris Martinez, Illustrations by Tasha José
Cell-free protein synthesis (CFPS) workflows allow for fast, scalable and cost-effective single-chain antibody fragment production. NEB scientists have outlined approaches to quickly and efficiently screen the discovery and initial characterization of novel antibody fragments with CFPS.
You have been idle for more than 20 minutes, for your security you have been logged out. Please sign back in to continue your session.
Please sign in to continue shopping.
Institution Changed
Your profile has been mapped to an Institution, please sign back for your profile updates to be completed.
Sign in to your NEB account
To save your cart and view previous orders, sign in to your NEB account. Adding products to your cart without being signed in will result in a loss of your cart when you do sign in or leave the site.